Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Hepatitis C

  Free Subscription

Articles published in Transfusion

Retrieve available abstracts of 24 articles:
HTML format
Text format

Single Articles

    February 2018
  1. SHAN Z, Huang J, Liao Q, Huang K, et al
    Association of killer cell immunoglobulin-like receptors with spontaneous clearance of hepatitis C virus in the Chinese population.
    Transfusion. 2018 Feb 15. doi: 10.1111/trf.14527.
    PubMed     Text format     Abstract available

    January 2018
  2. ROCHA D, Andrade E, Godoy DT, Fontana-Maurell M, et al
    The Brazilian experience of nucleic acid testing to detect human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in blood donors.
    Transfusion. 2018 Jan 30. doi: 10.1111/trf.14478.
    PubMed     Text format     Abstract available

    December 2017
  3. GALEL SA, Simon TL, Williamson PC, AuBuchon JP, et al
    Sensitivity and specificity of a new automated system for the detection of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus nucleic acid in blood and plasma donations.
    Transfusion. 2017 Dec 17. doi: 10.1111/trf.14457.
    PubMed     Text format     Abstract available

    August 2017
  4. GAO Z, Zhang Y, Shan H, Shi L, et al
    A 30-year systematic review and meta-analysis of hepatitis B virus among blood donors in mainland China: revealing increase of new threats.
    Transfusion. 2017;57:1988-1997.
    PubMed     Text format     Abstract available

    July 2017
  5. TWAGIRUMUGABE T, Swaibu G, Bergstrom T, Walker TD, et al
    Low prevalence of hepatitis C virus RNA in blood donors with anti-hepatitis C virus reactivity in Rwanda.
    Transfusion. 2017 Jul 3. doi: 10.1111/trf.14204.
    PubMed     Text format     Abstract available

    June 2017
  6. VIEIRA PCM, Lamarao LM, Amaral CEM, Correa ASM, et al
    Residual risk of transmission of human immunodeficiency virus and hepatitis C virus infections by blood transfusion in northern Brazil.
    Transfusion. 2017 Jun 7. doi: 10.1111/trf.14146.
    PubMed     Text format     Abstract available

    May 2017
  7. CZERWINSKI M, Grabarczyk P, Stepien M, Kubicka-Russel D, et al
    What weighs more-low compliance with self-deferral or minor medical procedures? Explaining the high rate of hepatitis C virus window-period donations in Poland.
    Transfusion. 2017 May 28. doi: 10.1111/trf.14163.
    PubMed     Text format     Abstract available

    April 2017
  8. BISWAS A, Firdaus R, Gupta D, Ghosh M, et al
    Interferon lambda3 gene (IL28B) is associated with spontaneous or treatment-induced viral clearance in hepatitis C virus-infected multitransfused patients with thalassemia.
    Transfusion. 2017 Apr 16. doi: 10.1111/trf.14070.
    PubMed     Text format     Abstract available

    March 2017
  9. BLANCO S, Balangero MC, Valle MC, Montini OL, et al
    Usefulness of nucleic acid testing to reduce risk of hepatitis B virus transfusion-transmitted infection in Argentina: high rate of recent infections.
    Transfusion. 2017;57.
    PubMed     Text format     Abstract available

    February 2017
  10. GUO Z, Fu P, Yin Y, Wang F, et al
    The characteristics of hepatitis B surface antigen (HBsAg)-negative hepatitis B virus (HBV) infection in Chinese blood donors: a follow-up study of donors tested negative for HBsAg and reactive for simultaneous nucleic acid testing of HBV, hepatitis C
    Transfusion. 2017 Feb 5. doi: 10.1111/trf.14014.
    PubMed     Text format     Abstract available

    January 2017
  11. VENDRAMIN C, McGuckin S, Alwan F, Westwood JP, et al
    A single-center prospective study on the safety of plasma exchange procedures using a double-viral-inactivated and prion-reduced solvent/detergent fresh-frozen plasma as the replacement fluid in the treatment of thrombotic microangiopathy.
    Transfusion. 2017;57:131-136.
    PubMed     Text format     Abstract available

  12. GALLIAN P, Couchouron A, Dupont I, Fabra C, et al
    Comparison of hepatitis E virus nucleic acid test screening platforms and RNA prevalence in French blood donors.
    Transfusion. 2017;57:223-224.
    PubMed     Text format    

    October 2016
  13. MAFIRAKUREVA N, Mapako T, Khoza S, Emmanuel JC, et al
    Cost effectiveness of adding nucleic acid testing to hepatitis B, hepatitis C, and human immunodeficiency virus screening of blood donations in Zimbabwe.
    Transfusion. 2016 Oct 2. doi: 10.1111/trf.13858.
    PubMed     Text format     Abstract available

    June 2016
  14. REZAEI N, Amini-Kafiabad S, Maghsudlu M, Abolghasemi H, et al
    Risk factor analysis of hepatitis C virus seropositivity in Iranian blood donors: a case-control study.
    Transfusion. 2016 Jun 6. doi: 10.1111/trf.13660.
    PubMed     Text format     Abstract available

    May 2016
  15. QUIROGA JA, Avellon A, Bartolome J, Andreu M, et al
    Detection of hepatitis C virus (HCV) core-specific antibody suggests occult HCV infection among blood donors.
    Transfusion. 2016 May 17. doi: 10.1111/trf.13645.
    PubMed     Text format     Abstract available

    January 2016
  16. MAPAKO T, Janssen MP, Mvere DA, Emmanuel JC, et al
    Impact of using different blood donor subpopulations and models on the estimation of transfusion transmission residual risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus in Zimbabwe.
    Transfusion. 2016 Jan 22. doi: 10.1111/trf.13472.
    PubMed     Text format     Abstract available

  17. SLOT E, Janssen MP, Marijt-van der Kreek T, Zaaijer HL, et al
    Two decades of risk factors and transfusion-transmissible infections in Dutch blood donors.
    Transfusion. 2016;56:203-14.
    PubMed     Text format     Abstract available

    October 2015
  18. ALLISON KM, Faddy HM, Margaritis A, Ismay S, et al
    The impact on blood donor screening for human immunodeficiency virus, hepatitis C virus, and hepatitis B virus using plasma from frozen-thawed plasma preparation tubes.
    Transfusion. 2015 Oct 12. doi: 10.1111/trf.13372.
    PubMed     Text format     Abstract available

  19. MOORMAN AC, Stramer SL, Schaefer MK, Collier MG, et al
    Incident hepatitis among repeat blood donors: A sentinel event signaling possible health care-associated infection and need for reporting to public health authorities.
    Transfusion. 2015;55:2531-3.
    PubMed     Text format    

    September 2015
  20. GRABARCZYK P, Koppelman M, Boland F, Sauleda S, et al
    Inclusion of human immunodeficiency virus Type 2 (HIV-2) in a multiplex transcription-mediated amplification assay does not affect detection of HIV-1 and hepatitis B and C virus genotypes: a multicenter performance evaluation study.
    Transfusion. 2015;55:2246-55.
    PubMed     Text format     Abstract available

    June 2015
  21. KIELY P
    Screening blood donors for hepatitis C virus: the challenge to consider cost-effectiveness.
    Transfusion. 2015;55:1143-6.
    PubMed     Text format    

    May 2015
  22. LAPERCHE S, Nubling CM, Stramer SL, Brojer E, et al
    Sensitivity of hepatitis C virus core antigen and antibody combination assays in a global panel of window period samples.
    Transfusion. 2015 May 27. doi: 10.1111/trf.13179.
    PubMed     Text format     Abstract available

  23. CUSTER B, Kessler D, Vahidnia F, Leparc G, et al
    Risk factors for retrovirus and hepatitis virus infections in accepted blood donors.
    Transfusion. 2015;55:1098-107.
    PubMed     Text format     Abstract available

    March 2015
  24. GUPTA S, Fenves A, Nance ST, Sykes DB, et al
    Hyperhemolysis syndrome in a patient without a hemoglobinopathy, unresponsive to treatment with eculizumab.
    Transfusion. 2015;55:623-8.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis C is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.